Table 1 Demographic and baseline characteristics of participants in the study
Characteristics | BSE (n = 44) | Placebo (n = 45) | All (n = 89) |
|---|---|---|---|
Age (years) | 65 ± 7 | 61 ± 10 | 63 ± 9 |
Male (n (%)) | 29 (66) | 28 (62) | 57 (64) |
Fasting glucose (mmol l−1) | 6.4 ± 0.2 | 6.4 ± 0.2 | 6.4 ± 0.2 |
HbA1c (mmol mol−1) | 38.2 ± 3.9 | 38.1 ± 4.5 | 38.2 ± 4.1 |
BMIa | 32.1 ± 3.8 | 32.2 ± 3.9 | 32.1 ± 3.8 |
HOMA-B | 118.1 ± 30.0 | 119.1 ± 28.1 | 118.6 ± 28.9 |
HOMA-IR | 5.4 ± 3.2 | 5.4 ± 3.4 | 5.4 ± 3.3 |
Fasting insulin (mIE l−1) | 18.8 ± 10.8 | 19.0 ± 11.5 | 18.9 ± 11.1 |
Fasting C-peptide (nmol l−1) | 1.22 ± 0.45 | 1.22 ± 0.39 | 1.22 ± 0.42 |
Fasting C-peptide-to-insulin ratio | 0.074 ± 0.022 | 0.073 ± 0.020 | 0.074 ± 0.021 |
Bilirubin (μmol l−1) | 10.0 ± 4.1 | 9.8 ± 4.5 | 9.9 ± 4.3 |
ALP (μkat l−1) | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.1 ± 0.3 |
GGT (μkat l−1) | 0.7 ± 0.4 | 0.7 ± 0.5 | 0.7 ± 0.5 |
AST (μkat l−1) | 0.4 ± 0.2 | 0.5 ± 0.2 | 0.4 ± 0.2 |
ALT (μkat l−1) | 0.5 ± 0.3 | 0.6 ± 0.3 | 0.6 ± 0.3 |
Fatty liver indexb | 75.9 ± 20.5 | 76.9 ± 17.4 | 76.4 ± 18.9 |
Total cholesterol (mmol l−1) | 5.0 ± 1.1 | 5.1 ± 1.0 | 5.1 ± 1.0 |
LDL (mmol l−1) | 3.4 ± 1.0 | 3.5 ± 1.0 | 3.5 ± 1.0 |
HDL (mmol l−1) | 1.4 ± 0.4 | 1.3 ± 0.4 | 1.4 ± 0.4 |
Triglycerides (mmol l−1) | 1.4 ± 0.6 | 1.5 ± 0.6 | 1.5 ± 0.6 |
Creatinine (μmol l−1) | 82.1 ± 16.3 | 74.9 ± 12.5 | 78.5 ± 14.9 |
Estimated glomerular filtration rate (ml min−1 1.73 m−2) | 71.4 ± 11.0 | 78.8 ± 10.2 | 75.1 ± 11.1 |
Baseline physical activity (metabolic minutes per week)c | 2410 ± 1414 | 2225 ± 2028 | 2317 ± 1704 |
Food frequency scored | 4.7 ± 1.3 | 4.7 ± 2.3 | 4.7 ± 1.8 |